COVID 19: Relationship of the epidemiological pattern of COVID-19 between China and Italy

Authors

DOI:

https://doi.org/10.33448/rsd-v9i7.4840

Keywords:

Coronavirus infections; Epidemiology; Risk factors.

Abstract

The study aimed to analyze the epidemiological pattern of COVID-19 between Italy and China. The question that guided the review was: What were the epidemiological factors that led to the expression of COVID-19 between China and Italy? The search for the articles was carried out in April 2020 in the following databases: Scielo, Pubmed, VHL, ScienceDirect and Medline, using the following keywords: Coronavirus infections, epidemiology and risk factors. Studies show notable differences in the mortality rate between Asian and European populations. Three risk factors for worsening due to COVID-19 were listed: male gender, advanced age (older than 60 years) and the presence of comorbidities, especially chronic ones. Such factors were predominant mainly in Italy, compared to China. Hypertension, diabetes, cardiovascular diseases and cerebrovascular diseases are considered to be significant risk factors for COVID-19 and its worsening. Studies show that for both countries, being elderly and male increases the risk of contracting the disease in its most severe form. Further, more in-depth studies are needed regarding the harmful effects of chronic diseases as risk factors for COVID-19 infection.

References

Bordi L., Nicastri E., Scorzolini L., Caro A.D., Capobianchi M.R., Castilletti C. & Lalle E. (2020). Differential Diagnosis of Illness in Patients Under Investigation for the Novel Coronavirus (SARS-CoV-2). (2020). Italy, February. Eurosurveillance. Feb 27; 25,(8). 2000170

Chen J., Qi, T., Liu L., Ling Y., Qian Z., Li, T. & Lu H. (2020).Clinical progression of patients with COVID-19 in Shanghai, China.Journal of Infection. 80,(20). 1–6.

Guo Y.R., Cao Q.D., Hong Z.S., Tan Y.Y., Chen S.D., Jin H.J., Tan K.S. & Wang D.Y. (2020). The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak – an update on the status.Military Medical Research. 7,(11). 1-10.

Law S., Leung A.W. & Xu C. (2020). Severe acute respiratory syndrome (SARS) and coronavirus disease-2019 (COVID-19): From causes to preventions in Hong Kong. Int J Infect Dis.4,(94). 156–163.

Lippi G., Mattiuzzi C., Sanchis-Gomar F. & Henry,B.M. (2020). Clinical and demographic characteristics of patients dying from COVID-19 in Italy versus China. 11,(4). 1-9.

Lorenzo G.D. & Trolio R.D. (2020). Coronavirus Disease (COVID-19) in Italy: Analysis of Risk Factors and Proposed Remedial Measures. Front in Medicine. 7,(140).

Organização Pan-Americana de Saúde. (2020). Folha informativa – COVID-19 (doença causada pelo novo coronavírus). Acesso em 15 de abril, Disponível em: https://www.paho.org/bra/index.php?option=com_content&view=article&id=6101:covid19&Itemid=875

Park M., Cook A.R., Yinxiaohe J.T. & Dickens B.L. (2020). A Systematic Review of COVID-19 Epidemiology Based on Current Evidence. Journal of Clinical Medicine. 9, (4), 967-73.

Porcheddu R. Serra C., Kelvin D., Kelvin N. & Rubino S. (2020). Similarity in Case Fatality Rates (CFR) of COVID-19/SARS-COV-2 in Italy and China.The Journal of Infection in Developing Countries.14, (2).1-4.

Remuzzi A. & Remuzzi G. (2020). Covid-19 and Italy: what next? The lancet. 11.(395), 1225-1228.

Rubino, S., Kelvin, N., Bermejo-Martin, J.F. & Kelvin, D.J. (2019). As COVID-19 cases, deaths and fatality rates surge in Italy, underlying causes require investigation. Infect DevCtries. 14,(3). 265-267.

Spiteri G., Fielding J., Diercke M., Campese C., Enouf, V., Gaymard A., Bella, A., Sognamiglio, P., Moros M.J.S. & Riutort A.N. (2020).First cases of coronavirus disease 2019 (COVID-19) in the WHO European Region, 24 January to 21 February 2020.Euro Surveill. 25,(9). 200- 178.

Stefanelli, P., Faggioni, G., Presti, A.L., Fiore, S., Marchi, A., Benedetti, E. & Lista, F. (2020). Whole genome and phylogenetic analysis of two SARS-CoV-2 strains isolated in Italy in January and February 2020: additional clues on multiple introductions and further circulation in Europe.(2020).Euro Surveill. 25,(13). 200-305

Wang R., Pan M., Zhang X., Han M., Han M., Fan X. & Shen L. (2020). Epidemiological and clinical features of 125 Hospitalized Patients with COVID-19 in Fuyang, Anhui, China. Int J Infect Dis. Apr 11,(95). 421-428.

World Health Organization.(2020). SARS (Severe Acute Respiratory Syndrome).Acessoem 15 de abril, Disponível em: https://www.who.int/ith/diseases/sars/en/

Wu C., Chen X., Cai., Y., Xia J., Zhou X., Xu S. & Song Y. (2020). Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patientes With Coronavirus Disease 2019 Pneumonia in Wuhan China. JAMA Intern Med. Retrieved from https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2763184

Yi Y., Lagniton P.N.P., Ye S., Li E. & Xu R.H. (2020). COVID-19: what has been learned and to be learned about the novel coronavirus disease. International Journal of Biological Sciences.16,(10). 1753-1766.

Published

11/06/2020

How to Cite

FERREIRA, C. M.; ALMEIDA, D. D. C. de; MATTOS, M. L. A. D. de; OLIVEIRA, T. K. de B. de. COVID 19: Relationship of the epidemiological pattern of COVID-19 between China and Italy. Research, Society and Development, [S. l.], v. 9, n. 7, p. e754974840, 2020. DOI: 10.33448/rsd-v9i7.4840. Disponível em: https://rsdjournal.org/index.php/rsd/article/view/4840. Acesso em: 14 nov. 2024.

Issue

Section

Review Article